Particularly high activity for eye tumor treatments
IsoSeed® I25.S16 is used for the treatment of eye tumors, such as uveal melanomas and retinoblastomas. As an I-125 source, it emits low-energy photon radiation with greater tissue penetration than Ru-106 beta radiation, offering an additional treatment option for cases where Ru-106 Eye Applicators may not be suitable.
Key Features
Have a look at the white paper “Therapeutic Modalities for Uveal Melanoma and Retinoblastoma: Pros and Cons” written by Prof. Bertil Damato, one of the world’s leading ocular oncologists.
Guaranteed Biocompatibility
The titanium capsule of IsoSeed® I25.S16 meets ASTM F67 requirements. The finished products have been tested for biocompatibility.
Calibration
The certified source strength is based on air kerma measurements of IsoSeed® which are traceable to the primary standard of the PTB (Physikalisch-Technische Bundesanstalt = National Metrology Institute of Germany). Along with the NIST (National Institute of Standards and Technology), the PTB is a member of the Mutual Recognition Agreement.
Quality “Made in Germany”
The seed production at Eckert & Ziegler Medical is performed at the manufacturing facility in Berlin, Germany. It operates under strict quality and regulatory standards. Each single IsoSeed® is required to pass rigorous quality inspections at every production stage before proceeding to the next step.
Intraocular Melanoma Treatment with Brachytherapy
Publications
